Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Change in Intangibles: 2023-2025

  • Mereo BioPharma Group's Change in Intangibles fell 57.14% to $300,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $699,000 for FY2024, which is 66.83% up from last year.
  • According to the latest figures from Q1 2025, Mereo BioPharma Group's Change in Intangibles is $300,000, which was up 30,100.00% from -$1,000 recorded in Q2 2024.
  • Mereo BioPharma Group's 5-year Change in Intangibles high stood at $700,000 for Q1 2024, and its period low was -$1,000 during Q2 2024.
  • For the 3-year period, Mereo BioPharma Group's Change in Intangibles averaged around $354,500, with its median value being $359,500 (2023).
  • Per our database at Business Quant, Mereo BioPharma Group's Change in Intangibles soared by 67.06% in 2024 and then slumped by 57.14% in 2025.
  • Quarterly analysis of 3 years shows Mereo BioPharma Group's Change in Intangibles stood at $419,000 in 2023, then soared by 67.06% to -$1,000 in 2024, then plummeted by 57.14% to $300,000 in 2025.
  • Its Change in Intangibles was $300,000 in Q1 2025, compared to -$1,000 in Q2 2024 and $700,000 in Q1 2024.